Reaction Details |
| Report a problem with these data |
Target | Alpha-2A adrenergic receptor [16-465] |
---|
Ligand | BDBM50019492 |
---|
Substrate/Competitor | n/a |
---|
Ki | 0.95±n/a nM |
---|
Comments | PDSP_1648 |
---|
Citation | Naselsky, DP; Ashton, D; Ruffolo, RR; Hieble, JP Rabbit alpha2-adrenoceptors: both platelets and adipocytes have alpha2A-pharmacology. J Pharmacol Exp Ther298:219-25 (2001) [PubMed] |
---|
More Info.: | Get all data from this article |
---|
|
Alpha-2A adrenergic receptor [16-465] |
---|
Name: | Alpha-2A adrenergic receptor [16-465] |
Synonyms: | ADA2A_RAT | Adra2a | Adrenaline 2 | Alpha-2A adrenergic receptor | Alpha-2A adrenoceptor | Alpha-2A adrenoreceptor | Alpha-2AAR | Alpha-2D adrenergic receptor | Alpha2 Adrenoreceptor | CA2-47 | adrenergic Alpha2A |
Type: | G-protein coupled receptor |
Mol. Mass.: | 48961.69 |
Organism: | Rattus norvegicus (rat) |
Description: | P22909[16-465] |
Residue: | 450 |
Sequence: | MGSLQPDAGNSSWNGTEAPGGGTRATPYSLQVTLTLVCLAGLLMLFTVFGNVLVIIAVFT
SRALKAPQNLFLVSLASADILVATLVIPFSLANEVMGYWYFGKVWCEIYLALDVLFCTSS
IVHLCAISLDRYWSITQAIEYNLKRTPRRIKAIIVTVWVISAVISFPPLISIEKKGAGGG
QQPAEPSCKINDQKWYVISSSIGSFFAPCLIMILVYVRIYQIAKRRTRVPPSRRGPDACS
APPGGADRRPNGLGPERGAGTAGAEAEPLPTQLNGAPGEPAPTRPRDGDALDLEESSSSE
HAERPQGPGKPERGPRAKGKTKASQVKPGDSLPRRGPGAAGPGASGSGQGEERAGGAKAS
RWRGRQNREKRFTFVLAVVIGVFVVCWFPFFFTYTLIAVGCPVPYQLFNFFFWFGYCNSS
LNPVIYTIFNHDFRRAFKKILCRGDRKRIV
|
|
|
BDBM50019492 |
---|
n/a |
---|
Name | BDBM50019492 |
Synonyms: | (+)2-(2-Methoxy-2,3-dihydro-benzo[1,4]dioxin-2-yl)-4,5-dihydro-1H-imidazole | (-)2-(2-Methoxy-2,3-dihydro-benzo[1,4]dioxin-2-yl)-4,5-dihydro-1H-imidazole | 2-(2,3-dihydro-2-methoxy-1,4-benzodioxin-2-yl)-4,5-dihydro-1H-imidazole | 2-(2-Methoxy-2,3-dihydro-benzo[1,4]dioxin-2-yl)-4,5-dihydro-1H-imidazole | 2-(2-methoxy-2,3-dihydrobenzo[b][1,4]dioxin-2-yl)-4,5-dihydro-1H-imidazole | 2-ethoxy-idazoxan | CHEMBL10332 | RX-821002 | RX821002 |
Type | Small organic molecule |
Emp. Form. | C12H14N2O3 |
Mol. Mass. | 234.2512 |
SMILES | COC1(COc2ccccc2O1)C1=NCCN1 |t:14| |
Structure |
|